Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 3981 | 292 | 0.9331 | 0.9197 | 0.0733 | 0.0725 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 3766 | 260 | 0.8868 | 0.8594 | 0.0690 | 0.0671 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 3687 | 223 | 0.8761 | 0.8594 | 0.0605 | 0.0671 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 3472 | 249 | 0.8152 | 0.8594 | 0.0717 | 0.0671 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 3379 | 380 | 0.7585 | 0.7158 | 0.1125 | 0.1036 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 3250 | 329 | 0.7388 | 0.7158 | 0.1012 | 0.1036 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 2846 | 276 | 0.6500 | 0.7158 | 0.0970 | 0.1036 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 3490 | 205 | 0.8309 | 0.8272 | 0.0587 | 0.0678 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 3291 | 245 | 0.7704 | 0.8272 | 0.0744 | 0.0678 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 3744 | 263 | 0.8804 | 0.8272 | 0.0702 | 0.0678 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 1 | 3055 | 234 | 0.7135 | 0.7245 | 0.0766 | 0.0810 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 3200 | 257 | 0.7444 | 0.7245 | 0.0803 | 0.0810 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 3 | 3095 | 266 | 0.7155 | 0.7245 | 0.0859 | 0.0810 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 3214 | 278 | 0.7426 | 0.7117 | 0.0865 | 0.0820 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 2 | 3209 | 265 | 0.7446 | 0.7117 | 0.0826 | 0.0820 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 3 | 2774 | 213 | 0.6478 | 0.7117 | 0.0768 | 0.0820 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 1 | 2726 | 316 | 0.6096 | 0.5849 | 0.1159 | 0.1183 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 2638 | 323 | 0.5855 | 0.5849 | 0.1224 | 0.1183 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 3 | 2505 | 292 | 0.5597 | 0.5849 | 0.1166 | 0.1183 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 2777 | 232 | 0.6437 | 0.6349 | 0.0835 | 0.0855 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2702 | 244 | 0.6217 | 0.6349 | 0.0903 | 0.0855 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2755 | 228 | 0.6392 | 0.6349 | 0.0828 | 0.0855 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 2487 | 271 | 0.5605 | 0.5897 | 0.1090 | 0.1058 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 2551 | 268 | 0.5774 | 0.5897 | 0.1051 | 0.1058 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 2784 | 288 | 0.6313 | 0.5897 | 0.1034 | 0.1058 |